Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC | 
| Reactivities | Human | 
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC | 
| Reactivities | Human | 
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD38 monoclonal antibody (daratumumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD70 monoclonal antibody (vorsetuzumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
Chikungunya virus human monoclonal antibody, clone E26D9
| Applications | IF, Neutralize | 
| Reactivities | Human | 
Chikungunya virus human monoclonal antibody, clone E26D9
| Applications | IF, Neutralize | 
| Reactivities | Human | 
Anti-NKp46 [Bab281], Human IgG1, kappa
| Applications | FC, IF, IP | 
| Reactivities | Human, Macaque | 
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. | 
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC | 
| Reactivities | Human | 
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB | 
| Reactivities | Human | 
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB | 
| Reactivities | Human | 
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC | 
| Reactivities | Human | 
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP | 
| Reactivities | Human, Monkey | 
Recombinant Anti-TDRD3 (Clone RAB-C419)
| Applications | ChIP, ELISA, IF | 
| Reactivities | Human | 
Recombinant Anti-FOXP4 (Clone RAB-S40)
| Applications | ELISA, FC, IF | 
| Reactivities | Human | 
Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF | 
| Reactivities | Human | 
